Overview
A Team Approach to Managing IPF: Patient, Pulmonology, and Respiratory Therapy Perspectives
Breakfast symposium held in conjunction with the AARC Congress 2019.
Registration is closed for this activity.
This symposium will focus on multidisciplinary IPF patient management. A panel consisting of a pulmonologist, respiratory therapist, and an IPF patient will discuss the importance of an accurate diagnosis, selection of pharmacotherapy, and the value of respiratory care plans. Hear patient perspectives on shared decision making and engage with the faculty panel via interactive iPad technology.
This educational activity is designed for respiratory therapists and other clinicians involved in the management of patients with IPF.
Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quality of life and diminishes life expectancy. Therapies are available that slow lung function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. Respiratory therapists need education on therapies and supportive care to educate and counsel patients with IPF, as well as optimize their care.
Upon completion of this activity, participants will be able to:
• Describe identifying risk factors for IPF and characteristics of the disease course
• Discuss the efficacy, safety, and tolerability of available pharmacotherapies for IPF and its comorbidities
• Formulate comprehensive care plans to improve IPF patients’ symptoms and quality of life
• Identify patient and caregiver needs from IPF diagnosis, to treatment, and through advanced stages
• Describe identifying risk factors for IPF and characteristics of the disease course
• Discuss the efficacy, safety, and tolerability of available pharmacotherapies for IPF and its comorbidities
• Formulate comprehensive care plans to improve IPF patients’ symptoms and quality of life
• Identify patient and caregiver needs from IPF diagnosis, to treatment, and through advanced stages
Marriott New Orleans
555 Canal St.
Bissonet Ballroom (3rd Floor)
New Orleans , LA 70130 USA
Click here to view location map
555 Canal St.
Bissonet Ballroom (3rd Floor)
New Orleans , LA 70130 USA
Click here to view location map
| 6:30 am | The Impact and burden of IPF on Patients |
| 6:50 am | Patient Perspectives on Diagnosis |
| 7:00 am | Pharmacotherapy for IPF |
| 7:15 am | Patient Perspectives on Therapy |
| 7:20 am | Addressing Patient Needs with Comprehensive Care Plans |
| 7:40 am | Patient Perspectives During Advanced Stages |
| 7:50 am | Panel Discussion; Q&A |
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.
Information disseminated during this educational session is not reflective of any position or endorsement of the American Association for Respiratory Care (AARC).
Michael P. Mohning, MD
Assistant Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
National Jewish Health
University of Colorado-Denver
Denver, CO
Assistant Professor
Division of Pulmonary, Critical Care & Sleep Medicine
Interstitial Lung Disease Program
National Jewish Health
University of Colorado-Denver
Denver, CO
Sheila B. Shearer, RRT, AE-C
Clinical Lead Respiratory Therapist
Cardiopulmonary Rehabilitation
Duke University Hospital
Durham, NC
Richard Goodrow
IPF Patient & Pulmonary Fibrosis Support Group Facilitator
New Orleans, LA
Continued Respiratory Care Education (CRCE) has been requested for this session through the American Association for Respiratory Care (AARC).
